In-Licensing Process: Steps to Accelerate Assessment and Agreement: Best Practice Summary

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

This 22-page document examines key processes that drive high-performing in-licensing operations. Nineteen best practices and more than a dozen narratives from business development executives at leading pharmaceutical companies detail the most effective ways to create quality, efficiency and clarity in evaluation, agreement and communication in in-licensing organizations. This document originated in a Best Practices, LLC consulting project.

Industries Profiled:
Pharmaceutical; Medical Device; Biotech; Health Care; Chemical

Companies Profiled:
AstraZeneca; Sanofi-aventis; Roche; Johnson & Johnson; Novartis; GlaxoSmithKline; Genentech; Bristol-Myers Squibb

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

In-Licensing Process: Steps to Accelerate Assessment and Agreement

ID: 4499

Features:

Words: 6,799

Published: Pre-2019

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6BE4629E1531FF08A85256DBB00623AAA
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/in-licensing-process-steps-to-accelerate-assessment-and-agreement?opendocument
18
19
20
21
22
23
24/bestp/domrep.nsf
25DB